Amyloid-like aggregates of short self-assembly peptide selectively induce melanoma cell apoptosis.

I 4 K 2 Y*, co-localizing with tyrosinase abundantly expressed in melanoma cells, is catalyzed by tyrosinase to self-assemble into amyloid-like aggregates around the nucleus. Such aggregates prevent the exchange of substances between nucleus and cytoplasm, leading to cell apoptosis. [Display omitted] With the rising global incidence of melanoma, new anti-melanoma drugs with low-inducing drug resistance and high selectivity are in urgent need. Inspired by the physiological events in which fibrillar aggregates formed by amyloid proteins are toxic to normal tissues, we here rationally design a tyrosinase responsive peptide, I 4 K 2 Y* (Ac-IIIIKKDopa-NH 2). Such peptide self-assembled into long nanofibers outside the cells, while it was catalyzed into amyloid-like aggregates by tyrosinase which was rich in melanoma cells. The newly formed aggregates concentrated around the nucleus of melanoma cells, blocking the exchange of biomolecules between the nucleus and cytoplasm and finally leading to cell apoptosis via the S phase arrest in cell cycle distribution and dysfunction of mitochondria. Furthermore, I 4 K 2 Y* effectively inhibited B16 melanoma growth in a mouse model but with minimal side effects. We believe that the strategy of combining the usage of toxic amyloid-like aggregates and in-situ enzymatic reactions by specific enzymes in tumor cells will bring profound implications for designing new anti-tumor drugs with high selectivity. [ABSTRACT FROM AUTHOR]